Dual-action hydrogel prevents brain cancer returning in 100% of test mice

Scientists at Johns Hopkins University have developed a treatment that could provide new hope for aggressive brain cancers. Injecting a drug-laden hydrogel into the brain after tumors have been surgically removed was found to launch a combined chemo- a… Continue reading Dual-action hydrogel prevents brain cancer returning in 100% of test mice

Pragmatic approach may be the way forward for clinical trials

That a new cancer trial is about to start in the US is positive but not out of the ordinary, right? Except it is. This trial will be one of the first undertaken in a real-world clinical setting and represents a new model for future clinical trials.Cont… Continue reading Pragmatic approach may be the way forward for clinical trials

New type of genetically-engineered T-cell may destroy solid cancer tumors

Cancer cells are notorious for evading detection by the body’s immune system, making them difficult to treat. But a promising new type of genetically engineered T-cell that can effectively destroy solid cancer tumors may be just what the doctor ordered… Continue reading New type of genetically-engineered T-cell may destroy solid cancer tumors

Synthetic protein tweak could lead to universal cancer immunotherapy

Scientists at ETH Zurich have made a breakthrough towards designing an off-the-shelf treatment for immunotherapy against cancer. A synthetic protein tweak can allow immune cells from any donor to be given to any patient without the risk of a dangerous … Continue reading Synthetic protein tweak could lead to universal cancer immunotherapy

Dual attack supercharges cells to eliminate metastatic breast cancer

Harnessing the immune system to fight cancer is an ever-evolving area of medical science, but among the most stubborn and least responsive to immunology therapies is metastatic breast cancer.Continue ReadingCategory: Medical, ScienceTags: Breast cancer… Continue reading Dual attack supercharges cells to eliminate metastatic breast cancer

Experimental vaccine reprograms cancer to launch immunotherapy attack

Scientists have developed a new type of cancer vaccine that shows promise in clearing out leukemia in mice. The technique involves reprogramming cancer cells into immune cells so that they can teach the immune system how to fight off the disease.Contin… Continue reading Experimental vaccine reprograms cancer to launch immunotherapy attack

Boiling peanuts reduces allergic responses in clinical trial

A first-of-its-kind clinical trial has tested whether slowly introducing small quantities of boiled peanuts to a child’s diet can treat allergies. After the year-long treatment, 80% of children in the trial could safely tolerate peanuts but the researc… Continue reading Boiling peanuts reduces allergic responses in clinical trial

New cancer therapy and vaccine uses CRISPR to turn tumors into traitors

Scientists at Brigham and Women’s Hospital (BWH) have found a way to fight cancer with cancer. The team genetically engineered cancer cells to release anti-cancer drugs at the site of established tumors, as well as stimulating the immune system against… Continue reading New cancer therapy and vaccine uses CRISPR to turn tumors into traitors

Immunotherapy-boosting chemo drug shows promise in clinical trial

A combination of immunotherapy and chemotherapy has shown promise for treating stage IV melanoma in a new clinical trial. The chemo drug targets a type of cell that suppresses the immune response, and together the two showed an increased response rate…. Continue reading Immunotherapy-boosting chemo drug shows promise in clinical trial

Impressive results from “game-changing” mRNA skin cancer vaccine trial

The first results from an advanced trial testing mRNA technology against cancer reveal 44% of patients fared better than those on conventional treatments alone. The preliminary announcement from Moderna reveals Phase 3 trials for its personalized mRNA … Continue reading Impressive results from “game-changing” mRNA skin cancer vaccine trial